Study for the effect of traditional Chinese medicine Intervention among the high-risk population of close contacts of COVID-19 cases

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200005952

Enrollment

Unknown

Registered

2022-04-30

Start date

2022-04-29

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona Virus Disease 2019 (COVID-19)

Interventions

control group:The control group is only provided general care measures within 5 days without taking Chinese herbs

treatment group:The treatment group is provided general care measures + traditional Chinese herbs intervention prescription in the first 5 days, and isolated at home in the next 5 days without taking

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Close contacts and individuals with high risk of exposure to SARS-CoV-2 of COVID-19 who live in isolation points; (2) Aged >=18 years; (3) Those who agreed to participate in the study and signed the informed concent.

Exclusion criteria

Exclusion criteria: 1. Those who have participated in other clinical trials within the past 3 months or are allergic to traditional Chinese medicine; 2. Severe hepatic and renal insufficiency.

Design outcomes

Primary

Measure	Time frame
Positive rate;	—

Secondary

Measure	Time frame
vomit;headache;Median time of virus negative;dry throat;sore throat;runny nose;fever;Viral loan;stuffy nose;cough;fatigue;poor appetite;sleep;	—

Countries

China

Contacts

Public ContactChen yuelai

chenyuelai@163.com+86 13020193726

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026